Travere Therapeutics
TVTX
TVTX
123 hedge funds and large institutions have $642M invested in Travere Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 49
63% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $4.51M
Holders
123
Holding in Top 10
–
Calls
$1.67M
Puts
$4.51M
Top Buyers
| 1 | +$14.1M | |
| 2 | +$8.44M | |
| 3 | +$6.31M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.28M |
| 5 |
Renaissance Technologies
New York
|
+$5.57M |
Top Sellers
| 1 | -$8.7M | |
| 2 | -$4.61M | |
| 3 | -$4.51M | |
| 4 |
Two Sigma Investments
New York
|
-$4.15M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$4M |